Form 4: Edgewell Chief Supply Chain Officer Reports Equity Transactions

Paul Hibbert, Edgewell Personal Care's Chief Supply Chain Officer, reported the vesting of performance stock equivalents and the grant of new restricted stock equivalents.

Summary

• Paul Hibbert, Chief Supply Chain Officer of Edgewell Personal Care Company (EPC), reported several equity transactions.
• On November 13, 2025, 5,773 Performance Stock Equivalents (PSEs) vested into common stock after satisfying performance conditions.
• An additional 4,149 PSEs, for which performance conditions were met on November 6, 2025, and time vesting conditions on November 13, 2025, also converted into common stock.
• A total of 4,600 shares of common stock were disposed of at a price of $18.39 per share to cover tax liabilities upon the vesting of PSEs.
• 10,580 PSEs did not meet the necessary performance conditions and were canceled on November 13, 2025.
• On November 14, 2025, Mr. Hibbert was granted 15,445 Restricted Stock Equivalents (RSEs), which will vest in one-third increments on the first three anniversaries of the grant date.
• Following these transactions, Mr. Hibbert beneficially owns 48,564.693 shares of common stock directly and 15,445 Restricted Stock Equivalents directly.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to executive compensation, including vesting of existing awards and a new grant. There are no unexpected positive or negative financial implications for the company's operations or outlook, making the sentiment neutral.

Positives

• Vesting of 5,773 Performance Stock Equivalents (PSEs) into common stock, indicating successful achievement of performance conditions.
• Vesting of an additional 4,149 PSEs into common stock, further demonstrating performance condition satisfaction.
• Grant of 15,445 new Restricted Stock Equivalents (RSEs), representing future equity compensation and continued alignment with company performance.

Negatives

• 10,580 Performance Stock Equivalents (PSEs) did not satisfy necessary performance conditions and were canceled.
• 4,600 shares of common stock were disposed of to cover tax liabilities upon the vesting of PSEs, reducing direct beneficial ownership.

Future Outlook

The newly granted Restricted Stock Equivalents (RSEs) are scheduled to vest in three equal annual installments, beginning November 14, 2026, indicating future equity compensation for the reporting person.

Industry Context

This Form 4 filing details routine equity compensation events for a senior executive at Edgewell Personal Care Company. Such filings are standard practice in publicly traded companies across various industries, reflecting the use of performance-based and time-based equity awards as part of executive compensation packages to align management incentives with shareholder interests.

Stakeholder Impact

• Shareholders: The vesting and grant of equity awards are part of the company's established compensation structure, which can lead to minor dilution over time but is intended to align executive incentives with shareholder value creation.
• Employees (specifically Paul Hibbert): The transactions represent a realization of previously granted performance-based compensation and a new grant of future equity, directly impacting the executive's personal wealth and long-term incentive.

Next Steps

• One-third of the 15,445 Restricted Stock Equivalents are scheduled to vest on November 14, 2026.
• One-third of the 15,445 Restricted Stock Equivalents are scheduled to vest on November 14, 2027.
• The final one-third of the 15,445 Restricted Stock Equivalents are scheduled to vest on November 14, 2028.

Key Dates

Keywords

Edgewell Personal Care, EPC, Paul Hibbert, Chief Supply Chain Officer, SEC Form 4, Insider Trading, Equity Compensation, Performance Stock Equivalents, Restricted Stock Equivalents, Stock Vesting, Share Ownership